Point-of-care susceptibility testing for gonococcus allows individualised antibiotic treatment despite high local resis- tance rates, sparing cephalosporin use.
< Most known genetic markers of resistance currently have a limited role in predicting phenotypic resistance, but evidence suggests their absence can accurately predict susceptibility.
< Modern microengineered nanotechnologies may provide the basis for point-of-care susceptibility testing in the near future. < Rapid tests remain dependent upon surveillance programmes to monitor for new emerging resistant strains of gonorrhoea.
Mendeley saves you time finding and organizing research
Choose a citation style from the tabs below